Document Detail


Subclinical endothelial dysfunction and low-grade inflammation play roles in the development of erectile dysfunction in young men with low risk of coronary heart disease.
MedLine Citation:
PMID:  22519624     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
The purpose of this study is to investigate the possible underlying pathogenesis of erectile dysfunction(ED) in young men with low risk of coronary heart disease and no well-known aetiology. To conduct this study, 122 patients with ED under the age of 40 were enrolled, along with 33 age-matched normal control subjects. The patients with ED had significantly higher levels of systolic blood pressure (SBP), total cholesterol and triglyceride, high sensitivity C-reactive protein (hs-CRP), greater carotid intima-media thickness (CIMT) and Framingham risk score (FRS) than the control group, though all of these values were within the respective normal range. Further, the brachial artery flow- mediated vasodilation (FMD) values were significantly lower in ED patients and correlated positively with the severity of ED (r = 0.714, p < 0.001). When these significant factors were studied in the multivariate logistic regression model, FMD, SBP, hs-CRP and FRS remained the statistical significance. The receiver-operating characteristic (ROC) analysis demonstrated that FMD had a high ability to predict ED in young male with low FRS [area under the curve (AUC) 0.921, p < 0.001]. The cutoff value of FMD <10.25% had sensitivity of 82.8% and specificity of 100% for diagnosis of ED. FRS and hs- CRP were also proven to be predictors of ED (AUC 0.812, p < 0.001; AUC 0.645, p = 0.011, respectively). The results of this study validated that subclinical endothelial dysfunction and low-grade inflammation may be the underlying pathogenesis of ED with no well-known aetiology. Young patients complaining of ED should be screened for cardiovascular risk factors and possible subclinical atherosclerosis. Measurement of FMD, hs-CRP and FRS can improve our ability to predict and treat ED, as well as subclinical cardiovascular disease early for young male.
Authors:
F Yao; Y Huang; Y Zhang; Y Dong; H Ma; C Deng; H Lin; D Liu; K Lu
Related Documents :
12457784 - Pravastatin in elderly individuals at risk of vascular disease (prosper): a randomised ...
19036464 - Anger expression and prognosis after a coronary event in women.
22606914 - Occupational physical activity and risk of coronary heart disease among active and non-...
10025494 - Comparison between men and women admitted to an inpatient rehabilitation unit after car...
23756274 - Preventable obstetrical interventions: how many caesarean sections can be prevented in ...
22541744 - Evaluation of myocardial infarction and coronary artery disease in subjects taking lopi...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-4-23
Journal Detail:
Title:  International journal of andrology     Volume:  -     ISSN:  1365-2605     ISO Abbreviation:  -     Publication Date:  2012 Apr 
Date Detail:
Created Date:  2012-4-23     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8000141     Medline TA:  Int J Androl     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
© 2012 The Authors. International Journal of Andrology © 2012 European Academy of Andrology.
Affiliation:
Division of Ultrasound, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China Division of Urology and Andrology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China Department of Cardiovascular Medicine, Key Laboratory on Assisted Circulation, Ministry of Health, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Coronary Sinus Lead Fragmentation and Migration.
Next Document:  Diagnostik von aspergillusinfektionen in der hämatologie und onkologie.